190 related articles for article (PubMed ID: 30347820)
1. Type I Interferon Signaling Is Required for Dacryoadenitis in the Nonobese Diabetic Mouse Model of Sjögren Syndrome.
Chaly Y; Barr JY; Sullivan DA; Thomas HE; Brodnicki TC; Lieberman SM
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347820
[TBL] [Abstract][Full Text] [Related]
2. Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
Lieberman SM; Kreiger PA; Koretzky GA
Immunology; 2015 Jun; 145(2):232-41. PubMed ID: 25581706
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptor 7 Is Required for Lacrimal Gland Autoimmunity and Type 1 Diabetes Development in Male Nonobese Diabetic Mice.
Debreceni IL; Chimenti MS; Serreze DV; Geurts AM; Chen YG; Lieberman SM
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322152
[TBL] [Abstract][Full Text] [Related]
4. CD8 T cells contribute to lacrimal gland pathology in the nonobese diabetic mouse model of Sjögren syndrome.
Barr JY; Wang X; Meyerholz DK; Lieberman SM
Immunol Cell Biol; 2017 Sep; 95(8):684-694. PubMed ID: 28465508
[TBL] [Abstract][Full Text] [Related]
5. Salivary-gland-protective regulatory T-cell dysfunction underlies female-specific sialadenitis in the non-obese diabetic mouse model of Sjögren syndrome.
Barr JY; Wang X; Kreiger PA; Lieberman SM
Immunology; 2018 Oct; 155(2):225-237. PubMed ID: 29750331
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Type I Interferon-Associated Chemokines and Cytokines in Lacrimal Glands of Nonobese Diabetic Mice.
Allred MG; Chimenti MS; Ciecko AE; Chen YG; Lieberman SM
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916486
[TBL] [Abstract][Full Text] [Related]
7. Sex Effects on Gene Expression in Lacrimal Glands of Mouse Models of Sjögren Syndrome.
Tellefsen S; Morthen MK; Richards SM; Lieberman SM; Rahimi Darabad R; Kam WR; Sullivan DA
Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5599-5614. PubMed ID: 30481277
[TBL] [Abstract][Full Text] [Related]
8. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status.
Ohno Y; Satoh K; Shitara A; Into T; Kashimata M
J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjögren's Syndrome.
Meng Z; Klinngam W; Edman MC; Hamm-Alvarez SF
PLoS One; 2017; 12(9):e0184781. PubMed ID: 28902875
[TBL] [Abstract][Full Text] [Related]
10. The miRNA Landscape of Lacrimal Glands in a Murine Model of Autoimmune Dacryoadenitis.
Singh Kakan S; Li X; Edman MC; Okamoto CT; Hjelm BE; Hamm-Alvarez SF
Invest Ophthalmol Vis Sci; 2023 Apr; 64(4):1. PubMed ID: 37010857
[TBL] [Abstract][Full Text] [Related]
11. Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndrome.
Fava RA; Kennedy SM; Wood SG; Bolstad AI; Bienkowska J; Papandile A; Kelly JA; Mavragani CP; Gatumu M; Skarstein K; Browning JL
Arthritis Res Ther; 2011; 13(6):R182. PubMed ID: 22044682
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice.
Kong L; Robinson CP; Peck AB; Vela-Roch N; Sakata KM; Dang H; Talal N; Humphreys-Beher MG
Clin Exp Rheumatol; 1998; 16(6):675-81. PubMed ID: 9844759
[TBL] [Abstract][Full Text] [Related]
13. Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice.
Hunger RE; Carnaud C; Vogt I; Mueller C
J Clin Invest; 1998 Mar; 101(6):1300-9. PubMed ID: 9502771
[TBL] [Abstract][Full Text] [Related]
14. High incidence of autoimmune dacryoadenitis in male non-obese diabetic (NOD) mice depending on sex steroid.
Takahashi M; Ishimaru N; Yanagi K; Haneji N; Saito I; Hayashi Y
Clin Exp Immunol; 1997 Sep; 109(3):555-61. PubMed ID: 9328136
[TBL] [Abstract][Full Text] [Related]
15. Testosterone Influence on Gene Expression in Lacrimal Glands of Mouse Models of Sjögren Syndrome.
Morthen MK; Tellefsen S; Richards SM; Lieberman SM; Rahimi Darabad R; Kam WR; Sullivan DA
Invest Ophthalmol Vis Sci; 2019 May; 60(6):2181-2197. PubMed ID: 31108549
[TBL] [Abstract][Full Text] [Related]
16. PPAR-α Agonist Fenofibrate Ameliorates Sjögren Syndrome-Like Dacryoadenitis by Modulating Th1/Th17 and Treg Cell Responses in NOD Mice.
Guo X; Dang W; Li N; Wang Y; Sun D; Nian H; Wei R
Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):12. PubMed ID: 35687344
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor inhibitor gene expression suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.
Zhu Z; Stevenson D; Schechter JE; Mircheff AK; Crow RW; Atkinson R; Ritter T; Bose S; Trousdale MD
Cornea; 2003 May; 22(4):343-51. PubMed ID: 12792478
[TBL] [Abstract][Full Text] [Related]
18. Review of genes potentially related to hyposecretion in male non-obese diabetic (NOD) mice, a Sjögren's syndrome model.
Ohno Y; Satoh K; Kashimata M
J Oral Biosci; 2023 Sep; 65(3):211-217. PubMed ID: 37209839
[TBL] [Abstract][Full Text] [Related]
19. Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.
Kim D; Kim JY; Jun HS
Oncotarget; 2016 Dec; 7(49):80298-80312. PubMed ID: 27880731
[TBL] [Abstract][Full Text] [Related]
20. Early Dry Eye Disease Onset in a NOD.H-2h4 Mouse Model of Sjögren's Syndrome.
Li L; Jasmer KJ; Camden JM; Woods LT; Martin AL; Yang Y; Layton M; Petris MJ; Baker OJ; Weisman GA; Petris CK
Invest Ophthalmol Vis Sci; 2022 Jun; 63(6):18. PubMed ID: 35727180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
